Discover
KPRX
Kiora Pharmaceuticals, Inc.
2.54
2 x 1.84
2 x 3.28
bid
ask
+
0.01
0.40%
2 @ 04:00 PM
2.55 +0.01 (0.39%)
| Ytd | 28.93% | |
| 1y | -9.93% |
2.52
day range
2.57
1.80
52 week range
2.86
| Open | 2.52 | Prev Close | 2.53 | Low | 2.52 | High | 2.57 | Mkt Cap | 11.24M |
| Vol | 4.49K | Avg Vol | 17.41K | EPS | -2.47 | P/E | N/A | Forward P/E | -1.48 |
| Beta | -0.29 | Short Ratio | 0.27 | Inst. Own | 48.34% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 2.60 | 200-d Avg | 2.40 | 1yr Est | 40.50 |
| Income Statement | |||
| Operating Expenses | 2.12M | ||
| Research and Development Expense | 2.08M | ||
| Selling, General and Administrative Expense | 1.38M | ||
| Operating Income | -2.12M | ||
| Net Income | -2.08M | ||
| Net Income Common Stock | -2.08M | ||
| Net Income Common Stock (USD) | -2.08M | ||
| Consolidated Income | -2.08M | ||
| Earnings per Basic Share | -0.34 | ||
| Earnings per Basic Share (USD) | -0.34 | ||
| Earnings per Diluted Share | -0.34 | ||
| Earning Before Interest & Taxes (EBIT) | -2.08M | ||
| Earning Before Interest & Taxes (USD) | -2.08M | ||
| Weighted Average Shares | 6.18M | ||
| Weighted Average Shares Diluted | 6.18M | ||
| Balance Sheet | |||
| Cash and Equivalents | 7.08M | ||
| Cash and Equivalents (USD) | 7.08M | ||
| Investments | 9.76M | ||
| Investments Current | 9.76M | ||
| Trade and Non-Trade Receivables | 1.09M | ||
| Current Assets | 21.26M | ||
| Property, Plant & Equipment Net | 360.39K | ||
| Total Assets | 23.78M | ||
| Debt Current | 172.43K | ||
| Total Debt | 333.02K | ||
| Current Liabilities | 2.37M | ||
| Debt Non-Current | 160.60K | ||
| Total Liabilities | 6.92M | ||
| Accumulated Retained Earnings (Deficit) | -158.71M | ||
| Accumulated Other Comprehensive Income | -255.80K | ||
| Shareholders Equity | 16.86M | ||
| Shareholders Equity (USD) | 16.86M | ||
| Assets Non-Current | 2.51M | ||
| Total Debt (USD) | 333.02K | ||
| Deferred Revenue | 1.25M | ||
| Goodwill and Intangible Assets | 2.06M | ||
| Liabilities Non-Current | 4.55M | ||
| Trade and Non-Trade Payables | 216.50K | ||
| Tax Assets | 1.82M | ||
| Tax Liabilities | 102.15K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 51.54K | ||
| Net Cash Flow from Financing | 4.92M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.88M | ||
| Capital Expenditure | -23.46K | ||
| Issuance (Purchase) of Equity Shares | 5.00M | ||
| Net Cash Flow from Investing | -6.89M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -6.87M | ||
| Net Cash Flow from Operations | -1.89M | ||
| Effect of Exchange Rate Changes on Cash | -16.57K | ||
| Share Based Compensation | 109.31K | ||